Taiho Ventures
CVC
Active
Menlo Park, United States
30
44M
20
3.75
6
0.33
5
- Areas of investment
Summary
The company was established in North America in United States. The main office of represented VC is situated in the California City.
The standard case for the fund is to invest in rounds with 7-8 partakers. Despite the Taiho Ventures, startups are often financed by The Column Group, OrbiMed, Foresite Capital. The meaningful sponsors for the fund in investment in the same round are The Column Group, OrbiMed, Foresite Capital. In the next rounds fund is usually obtained by The Column Group, OrbiMed, Invus.
The real fund results show that this VC is 0 percentage points less often commits exit comparing to other companies. The top activity for fund was in 2019. The top amount of exits for fund were in 2019. The fund is constantly included in 2-6 deals per year. The common things for fund are deals in the range of 50 - 100 millions dollars. Opposing the other organizations, this Taiho Ventures works on 1 percentage points more the average amount of lead investments.
Among the most popular portfolio startups of the fund, we may highlight Axial Biotherapeutics, Breakpoint Therapeutics, Harpoon Therapeutics. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. Among the most popular fund investment industries, there are Biopharma, Biotechnology. The fund has specific favorite in a number of founders of portfolio startups. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
Investor highlights
- Industry focus
- Stage focus
- Geo focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 30
- Lead investments
- 6
- Exits
- 5
- Rounds per year
- 3.75
- Follow on index
- 0.33
- Investments by industry
- Biotechnology (28)
- Therapeutics (19)
- Health Care (17)
- Medical (13)
- Life Science (8) Show 4 more
- Investments by region
-
- United States (21)
- United Kingdom (5)
- Germany (1)
- Netherlands (2)
- China (1)
- Peak activity year
- 2019
- Number of Unicorns
- 2
- Number of Decacorns
- 2
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 5
- Avg. valuation at time of investment
- 65M
- Group Appearance index
- 0.90
- Avg. company exit year
- 3
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Arcus Biosciences | 13 Nov 2017 | Biotechnology, Health Care, Medical, Therapeutics | Late Stage Venture | 107M | United States, California, Hayward |
| EpiBiologics | 20 Jul 2023 | Biotechnology, Health Care, Medical, Therapeutics | Early Stage Venture | 23M | United States, California, San Mateo |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.